These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22414700)

  • 1. The triad of success in personalised medicine: pharmacogenomics, biotechnology and regulatory issues from a Central European perspective.
    Mesko B; Zahuczky G; Nagy L
    N Biotechnol; 2012 Sep; 29(6):741-50. PubMed ID: 22414700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
    Desiere F; Romano Spica V
    N Biotechnol; 2012 Sep; 29(6):611-2. PubMed ID: 22504736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics: Systematically Quantifying the Literature.
    Hewitt JE
    J Law Med; 2018 Apr; 25(3):782-793. PubMed ID: 29978667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: the genomics of drug response.
    March R
    Yeast; 2000 Apr; 17(1):16-21. PubMed ID: 10797598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of personalized medicine in the disease genomic era.
    Hong KW; Oh B
    BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised medicine in the genome era.
    Chalmers D; Nicol D; Otlowski M; Critchley C
    J Law Med; 2013 Mar; 20(3):577-94. PubMed ID: 23600190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices.
    Fleck LM
    N Biotechnol; 2012 Sep; 29(6):757-68. PubMed ID: 22433081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New genetics, new ethics? Globalisation and its discontents.
    Glasner P; Rothman H
    Health Risk Soc; 2001 Nov; 3(3):245-59. PubMed ID: 15080126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Displaced agendas: current regulatory strategies for germline gene therapy.
    Marden E; Nelkin D
    McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merging genomic and phenomic data for research and clinical impact.
    Shublaq NW; Coveney PV
    Stud Health Technol Inform; 2012; 174():111-5. PubMed ID: 22491122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intersection of biotechnology and pharmacogenomics: health policy implications.
    Phillips KA
    Health Aff (Millwood); 2006; 25(5):1271-80. PubMed ID: 16966723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ethical and legal overview of pharmacogenomics: perspectives and issues.
    Sillon G; Joly Y; Feldman S; Avard D
    Med Law; 2008 Dec; 27(4):843-57. PubMed ID: 19202860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
    Hakim Z; Kucukarslan S
    Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical, social and legal implications of pharmacogenomics: a critical review.
    Moldrup C
    Community Genet; 2001; 4(4):204-14. PubMed ID: 12751484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.